Andreas Halvorsen acquired 4.89 Million Biomarin Pharmaceutical - Registered Shares shares worth $400 Million. That's 1.41% of their equity portfolio (26th largest holding). The investor owns 2.51% of the outstanding Biomarin Pharmaceutical - Registered Shares stock. The first Biomarin Pharmaceutical - Registered Shares trade was made in Q1 2016. Since then Andreas Halvorsen bought shares sixteen more times and sold shares on nine occasions. The investor's estimated purchase price is $420 Million, resulting in a loss of 4.9%.